Soy attracts attention for its health benefits, such as lowering cholesterol or preventing breast and colon cancer. Soybeans contain isoflavones, which act as phytoestrogens. Even though isoflavones have beneficial health effects, a role for isoflavones in the initiation and progression of diseases including cancer is becoming increasingly recognized. While data from rodent studies suggest that neonatal exposure to genistein (the predominant isoflavone in soy) disrupts normal reproductive function, its role in ovarian cancers, particularly granulosa cell tumors (GCT), is largely unknown. Our study aimed to define the contribution of a soy diet in GCT development using a genetically modified mouse model for juvenile GCTs (JGCT; Smad1 Smad5 conditional double knockout mice) as well as a human JGCT cell line (COV434). While dietary soy cannot initiate JGCT development in mice, we show that it has dramatic effects on GCT growth and tumor progression compared to a soy-free diet. Loss of Smad1 and Smad5 alters estrogen receptor alpha (Esr1) expression in granulosa cells, perhaps sensitizing the cells to the effects of genistein. In addition, we found that genistein modulates estrogen receptor expression in the human JGCT cell line and positively promotes cell growth in part by suppressing caspase-dependent apoptosis. Combined, our work suggests that dietary soy consumption has deleterious effects on GCT development.
INTRODUCTION
Nutrigenomics (i.e., the role of dietary compounds in regulation of gene expression) has long been investigated in regard to carcinogenesis [1, 2] . Among these dietary components, isoflavones are a category of phytoestrogens found in soy with both estrogenic and antiestrogenic effects whose role in tumor initiation and development has yielded conflicting results [3, 4] . While there is extensive literature evaluating the role of phytoestrogens on cancer risks, particularly in breast cancers [1, 2] , its role on other types of cancers, such as ovarian cancer, has received less attention. In humans, studies have shown that isoflavones have an inverse association with epithelial ovarian cancer risk, demonstrating their potential role as suppressors of tumor growth [5, 6] . However, there is evidence that isoflavones may also initiate or promote tumor development in vivo and in vitro [7, 8] .
Ovarian cancer remains the leading cause of death among gynecological malignancies. Juvenile granulosa cell tumors (JGCT) are a rare form of ovarian cancer that occurs before the age of 30 in humans and is a subset of sex cord/stromal tumors. We previously generated a mouse model containing double conditional deletion of the bone morphogenetic protein (BMP) receptor signaling SMADs (Smad1 Smad5 dKO) in granulosa cells, which develops granulosa cell tumors with full penetrance, in addition to peritoneal and lymphatic metastasis [9] . This mouse model phenocopies the human form of JGCT [10] .
Genistein, the main soy isoflavone, has the highest estrogenic potency of all soy constituents [11] . It has been shown to have anticancer properties in prostate [12] [13] [14] and breast cancer [15] [16] [17] . In contrast, dietary isoflavones promote GCT development in a spontaneous mouse model that is genetically susceptible to GCT, although the mechanism of action is not fully understood [18] . Data from rodent studies suggest that neonatal exposure to genistein disrupts normal reproductive function [11, 19] . Besides its specific action as an inhibitor of tyrosine kinase activity [20] , genistein has a structural similarity with 17-b estradiol, although its relative affinity for estrogen receptors is 1000-fold lower [21] . This enables its binding to both estrogen receptor isoforms ESR1 (ERalpha) and ESR2 (ERbeta) despite a higher affinity for ESR2 [22] . As a result, genistein could stimulate estrogen receptor-mediated pathways and modulate cell growth [23] . The aim of this study was to determine the impact of soy on GCT development using Smad1 Smad5 dKO mice as a model for JGCT and to determine if genistein affects growth of human JGCT cells.
MATERIALS AND METHODS

Generation of Smad1 Smad5 Double Knockout Mice
All experimental animals were maintained on a C57BL/6J/129S7/SvEvBrd mixed hybrid background in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and with approved animal protocols from Baylor College of Medicine. The alleles for this study and the generation of Smad1 Smad5 double knockout (dKO) mice have been described in detail previously [9] . 
Rodent Diets
For studies on dietary soy, breeder mice were kept on a diet that contained dehulled soybean meal as the predominant protein source in addition to dehydrated alfalfa (PicoLab Rodent diet 20 [5053] ). According to the manufacturer, this diet contained a total isoflavone concentration of 200-400 parts per million (ppm). To determine the effect of a soy-free diet, breeder mice were fed a diet that contained no soy or alfalfa and had an isoflavone concentration lower than 20 ppm (Teklad global soy protein-free extruded rodent diet [2920] ). Both diets contained the same composition of protein (;20%), fat (;5%), and carbohydrate (;53%), and a detailed description of both diets is presented in Supplemental Table S1 (all Supplemental Data are available online at www.biolreprod.org).
Fertility Analysis
Fertility analysis was carried out as previously described [9] . At 6 wk of age, females were housed with a known fertile adult male continuously for 6 mo. The numbers of pups per litter and litters per month were recorded. Fertility test cages were set up for both diets (soy and soy free) for all genotypes (control and dKO). The difference in the mean number of pups per litter at Months 1-3 and 4-6 was analyzed by analysis of variance (ANOVA) and a Tukey honestly significant difference (HSD) test.
Survival Curve
Control (n ¼ 10 for each diet) and Smad1 Smad5 dKO mice (soy-based diet, n ¼ 15; soy-free diet, n ¼ 10) were weaned at 3 wk of age and maintained on the same diet as their breeders (soy based or soy free) to determine the impact of diet on survival. Mice were housed in the same room with identical microisolator cages, bedding, and light:dark cycles. Water and food were provided ad libitum. Mice were weighed weekly and monitored for signs of physical distress or gross tumor development. At necropsy, mice were examined for visible ovarian tumors or metastases.
Tumor and Metastasis Incidence
A cohort of mice was housed for 9 mo for analysis of tumor and metastasis development. Control (n ¼ 5 for each diet), and Smad1 Smad5 dKO mice were fed the same diet as their breeders and housed as above (''Survival Curve''). All Smad1 Smad5 dKO mice died within the 9-mo period. Control mice and mice fed a soy-free diet (n ¼ 16) were euthanized at 9 mo of age. All of the mice were examined grossly for ovarian tumors and metastases, which were recorded as present or absent.
Hormone Assays
Blood was collected by cardiac puncture on isoflurane-anesthetized 12-wkold Smad1 Smad5 dKO and control mice, which were fed a soy-based or a soyfree diet. Serum was separated by centrifugation using microtainer serum separator tubes (Becton Dickenson) and stored at À208C until assayed. Serum concentration of estradiol (E 2 ) was measured by radioimmunoassay (RIA) at the University of Virginia Ligand Center for Research in Reproduction Ligand Assay and Analysis Core. The mouse E 2 assay has a sensitivity of 3.0 pg/ml, an intra-assay coefficient of variation of 6%, and an interassay coefficient of 11.4%.
Tissue Collection and Embedding
Mice were anesthetized by isoflurane inhalation and euthanized by cervical dislocation. Tissues were stored in 10% formalin for paraffin embedding or in RNALater (Ambion) at À808C until processed for RNA. Tissues were processed and embedded at the Human Tissue Acquisition and Pathology Core (Baylor College of Medicine) using standard protocols.
Histologic Analysis and Immunohistochemistry
Tissues were sectioned at 4-6 lm for histology or immunohistochemistry. For histologic analysis, sections were stained using Periodic Acid Schiff and counterstained with Gill hematoxylin. Immunohistochemistry was performed using the Vectastain ABC kit (Vector Laboratories) according to the manufacturer's instructions in triplicate on a minimum of three samples with a negative control (primary antibody omitted) run in parallel. Tissue sections were incubated overnight at 48C with goat anti-AMH (1:2000; Santa Cruz Biotechnology), washed, and then incubated for 1 h at room temperature with a biotinylated horse anti-goat secondary antibody (Vector Laboratories).
Immunoreactivity was visualized by 3,3 0 -diaminobenzidine HRP substrate (Vector Laboratories), and ovaries were counterstained with Harris hematoxylin.
Granulosa Cell Collection
Granulosa cells were collected as previously described from cre-negative Smad1 flox/flox Smad5 flox/flox female mice [24] . Prepubertal mice (21-23 days old) were injected intraperitoneally with 5 IU of equine chorionic gonadotropins (Calbiochem) to stimulate follicle growth, and granulosa cells were isolated 44 to 46 h later by puncturing large antral follicles and cells immediately lysed in RLT for RNA preparation.
COV434 Cell Culture and Reagents
The spontaneously immortalized COV434 cell line, which is derived from a primary human juvenile granulosa cell tumor, was purchased from Public Health England Culture Collections and maintained as described [25] . Phenol red-free media containing 10% FBS was used to assess responses to genistein and chemical inhibitors. Cells were treated with vehicle (0.1% dimethyl sulfoxide [DMSO]), genistein (5, 25, or 50 lM) (Tocris), ICI 182,780 (Tocris; an estrogen receptor antagonist devoid of any partial agonist effect and used at 1, 5, or 10 lM), or tamoxifen (Tocris; an estrogen receptor partial antagonist and used at 1, 5, or 10 lM). Cells were treated for the indicated times and then harvested or assayed as indicated in the text. All experiments were carried out a minimum of three independent times.
Genistein at a concentration of 5 lM is representative of the total plasma level found in soy formula-fed infants [26] or adults taking dietary supplements [27] . Genistein at 50 lM was chosen to relate to the serum genistein level found in mice fed a soy-based diet [26, 28, 29] , although this dose is up to 10-fold higher than the level found in soy formula-fed infant; 25 lM genistein was selected as an intermediate dose. A 10-lM concentration of ICI 182,780 (fulvestrant) was selected based on studies in rats [30, 31) , which showed that estradiol effects are antagonized at that concentration. We chose a dose of 10 lM for tamoxifen based on its effect on human granulosa-lutein cells [32] .
RNA Extraction and Quantitative Polymerase Chain Reaction
Total RNA was extracted using the RNeasy Micro or Mini kit based on the manufacturer's instructions (Qiagen). The ESR1 antibody and KGN cell RNA were provided by Drs. JoAnne Richards, Lisa Mullany, and Zhilin Liu (Baylor College of Medcine, Department of Molecular and Cellular Biology). Complementary DNA synthesis from total RNA was performed using the High Capacity RNA to cDNA Master Mix (Applied Biosystems) according to the manufacturer's instructions. The mRNA expression profiles of selected genes were analyzed by quantitative PCR (qPCR) using the ABI Prism 7500 StepOne sequence detection system and the Fast SYBR Green Master Mix (Applied Biosystems). The DD cycle threshold (CT) method was used to analyze the data, using Gapdh as the endogenous reference (Gapdh) for normalization and the mean of the control DCTs as the calibrator. This generates a mean value of ''1'' for the control samples. Primer sequences are listed in Supplemental Table S2 .
MTS Assay
COV434 cells were cultured in a 24-well plate at a density of 5 3 10 4 cells per well and were treated in phenol red-free medium as described with genistein, ICI 182,780, or tamoxifen. The number of viable cells was monitored by a MTS assay using the CellTiter 96 AQueous One nonradioactive cell proliferation assay (Promega) according to the manufacturer's instructions. After 3 h of culture, the number of viable cells was determined by measuring the absorbance at 490 nm using a 550 Bio-Rad plate reader (Bio-Rad). To assess any side effects of medium containing 10% FBS, COV434 cells were treated with genistein using charcoal-stripped FBS medium. For charcoal stripping, 1 g of dextran-coated charcoal was added to 50 ml of FBS and allowed to mix overnight at 48C. After centrifugation (2000 3 g for 15 min), charcoal was removed and the FBS filtered through a 0.22-lm filter (Millipore). The number of viable cells was assessed by MTS assay and compared to the latter experiment. No difference was found in the number of viable cells when treated with genistein in medium containing FBS or charcoalstripped FBS.
MANSOURI-ATTIA ET AL.
Caspase 3/7 Activity Assay COV434 cells were cultured in a 24-well plate at a density of 5 3 10 4 cells per well and were vehicle treated in phenol red-free medium as control, genistein (50 lM) for 30 min, or genistein (50 lM) in combination with a 30-min preincubation with either ICI 182,780 (10 lM) or tamoxifen (10 lM). Detection of caspase 3 and 7 activity was determined as recommended by the manufacturer (Promega). Background luminescence associated with cell culture and Caspase-Glo 3/7 reagents was subtracted from the experimental values. The luminescence of each sample was read by a luminometer (POLAR star Omega; BMG Labtech).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism 5 (GraphPad Software) or SPSS Statistic Version 22. Multiple comparisons were carried out using ANOVA followed by a Tukey HSD test. Unless otherwise stated, results were obtained from three independent experiments, each run in duplicate or triplicate. For the survival curve, statistical analysis was performed using the method of Kaplan-Meier estimator with a nonparametric log-rank test [33] .
RESULTS
A Soy-Free Diet Increases Survival of Smad1 Smad5 dKO Mice
Smad1 Smad5 dKO mice fed a soy-based diet develop granulosa cell tumors with full penetrance [9] . Because a previous study had shown that dietary isoflavones could enhance granulosa cell tumor development in a spontaneous mouse model of GCT [18] , we tested whether Smad1 Smad5 dKO mice bred on and fed a soy-free diet had a similar phenotype to those bred on and fed a soy-based diet. The two diets had no effect on the weight of Smad1 Smad 5 dKO mice (Supplemental Figure S1 ). Diet did not affect fertility of the control mice (Fig. 1A) . We previously published that Smad1 Smad5 dKO mice fed a soy-based diet are subfertile and become infertile at the time of tumor development [9] . Smad1 Smad5 dKO mice fed a soy-free diet are also subfertile compared to the controls but have a statistically similar mean number of pups per litter as the Smad1 Smad5 dKO mice fed a soy-based diet (Fig. 1A) [9] . However, fewer Smad1 Smad5 dKO mice fed a soy-free diet were infertile after 4 mo of breeding (one of six) compared to those fed a soy-based diet (two of the three that were still alive at that age). Because the infertility in soy-fed Smad1/5 dKO mice occurs in parallel with GCT development, this suggested to us that the soy-free diet might affect tumor initiation or progression [9, 10] .
To study the effect of diet on survival, a set of nonbreeding females was followed long term. Diet had no effect on survival of control mice (Fig. 1B) . All the Smad1 Smad5 dKO mice (15 of 15) fed a soy-based diet died within 47 wk (Fig. 1B) . In contrast, mice fed a soy-free diet survived significantly longer (up to 68 wk of age; Fig. 1B) . Overall, the 50% survival rate increased from 39 wk for the mice fed a soy-based diet to 62 wk for those fed a soy-free diet. Because of the changes in overall survival, we evaluated an additional cohort of nonbreeding mice fed a soy-based diet (n ¼ 12) or soy-free diet (n ¼ 16) for tumor and metastasis development. Our previous study demonstrated that the majority of Smad1 Smad5 dKO mice fed a soy-based diet had peritoneal and lymphatic metastases by 9 mo of age [9] . In this study, 75% of Smad1 Smad5 dKO mice (9 of 12) fed a soy-based diet develop metastasis by 9 mo; only 37.5% (6 of 16) Smad1 Smad5 dKO mice fed a soy-free diet showed evidence of tumor dissemination at 9 mo of age, which was a statistically significant difference (P , 0.05).
None of the control mice on either diet developed tumors, underscoring the idea that dietary soy accelerates GCT development only in genetically susceptible mice [18] . In histology sections, tumors were more well developed in 12-wkold Smad1 Smad5 dKO mice fed a soy-based diet as compared to those on a soy-free diet ( Fig. 2 ; compare panels B and C). However, both diets ultimately resulted in granulosa cell tumors with the same histology (Fig. 2, H and I) . We (control) and Smad1 flox/flox Smad5 flox/flox Amhr2 cre/þ (dKO) mice fed a soybased or soy-free diet. Female mice (6 wk of age) were mated to wild-type males, and the number of pups per litter was recorded over a 6-mo time frame. Data shown are mean 6 SEM, and statistical significance was determined by ANOVA and post hoc test. The number of breeding females at the beginning of the study is indicated (n). The mean pups per litter was calculated for Months 1 through 3 and Months 4 through 6 of breeding because of the appearance of infertility of Smad1 Smad5 dKO around 4 mo of age [9] . Bars with different letters represent statistically different means with P , 0.01. B) A soy-free diet increases survival of Smad1 Smad5 dKO mice. Mice were weaned at 3 wk of age and fed a soy-based or a soy-free diet. Survival curve for Smad1 flox/flox Smad5 flox/flox bred on and fed a soybased diet (control; n ¼ 10, blue line) or bred on and fed a soy-free diet (control; n ¼ 10, black dotted line), Smad1 flox/flox Smad5 flox/flox Amhr2 cre/þ bred on and fed a soy-based diet (dKO; n ¼ 15, red line), or bred on and fed a soy-free diet (dKO; n ¼ 10, black line). Statistical analysis was determined by log rank test. Different letters next to the lines indicate that the corresponding survival curve is statistically different from the others with P , 0.05.
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previously published that in Smad1 Smad5 dKO mice fed a soy-based diet, microscopic tumor foci were visible in the ovarian stroma and oviduct by 8 wk of age and that Smad1 Smad5 dKO tumors expressed the marker anti-Müllerian hormone (AMH) [9, 10] . We therefore examined AMH localization in Smad1 Smad5 dKO mice fed a soy-free diet at the same time point (8 wk of age; Fig. 3 ). AMH immunoreactivity was normally found in granulosa cells of growing follicles in control mice (Fig. 3, A and B) . We detected AMH-positive cells in the stroma and the oviduct of Smad1 Smad5 dKO mice fed a soy-based diet (Fig. 3, C and  D) . On a soy-free diet, tumor dissemination occurred similarly in mice fed a soy-based diet, as seen by a number of positive cells in the oviduct (Fig. 3, E and F) .
Genistein Increases Estrogen Receptor Expression and GCT Proliferation Through an Estrogen Receptor-Dependent Pathway
Both estrogen receptors ESR1 and ESR2 are present and functional in human granulosa cells [34] . In our study, both estrogen receptors were detected in wild-type granulosa cells in mice (Supplemental Figure S2A) . Smad1 Smad5 dKO tumors showed an upregulation in Esr1 compared to control granulosa cells, while Esr2 remained unchanged (Supplemental Figure  S2A) , even though Esr2 is the predominant estrogen receptor isoform in granulosa cells [35, 36] . We found that the human JGCT cell line COV434 expresses both ESR1 and ESR2 and showed a higher expression of ESR1 and ESR2 when compared
FIG. 2. GCT development in Smad1
Smad5 dKO mice fed a soy-based or soy-free diet. A) Ovary from a 12-wk-old Smad1 flox/flox Smad5 flox/flox (control) mouse fed a soy-free diet shows normal follicle development. B) Representative ovary from a 12-wk-old Smad1 Smad5 dKO mouse fed a soy-based diet with an enlarged ovary revealing tumor development. A portion of the tumor is seen on the left, black arrow. A higher magnification is presented as panel E, showing part of a tumor (Tu; arrow). C) Representative ovary from a 12-wk-old Smad1 Smad5 dKO mouse fed a soy-free diet shows a size comparable to control ovaries. However, a small extension of a tumor is seen on the right (arrow) invading the ovarian fat pad (FP; black arrow). A higher magnification is presented as panel F, showing Tu (arrow). D) Ovary from a 9-mo-old control mouse fed a soy-based diet with normal histology. G) Control ovary from a 9-mo-old mouse fed a soy-free diet with normal histology and evidence of ovulation (corpora lutea [CL] ). Both 9-mo-old Smad1 Smad5 dKO mice fed a soybased diet (H) or a soy-free diet (I) show a similar tumor histology. Bar ¼ 200 lm (A-I). AnF, antral follicle; Ov, ovary; Ovi, oviduct; PF, primary follicles; SF secondary follicle.
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to a nonovarian, nontumor cell line (human embryonic kidney [HEK293]) or compared to the human adult granulosa cell tumor cell line KGN (Supplemental Figure S2B) . Full-length ESR1 could also be detected in protein extracts of COV434 cells (Supplemental Figure S3) .
When control mice were maintained on a soy-free diet, Esr1 levels in granulosa cells were slightly but significantly higher than in granulosa cells from control mice fed a soy-containing diet, suggesting that in wild-type granulosa cells, soy may beneficially decrease expression of Esr1 (Fig. 4A) . Interestingly, however, when both Smad1 and Smad5 are deleted from granulosa cells, the opposite is true: in Smad1 Smad5 dKO cells, Esr1 was significantly increased in the presence of soy (Fig. 4A) . These data suggest a potential change in cell signaling caused by loss of Smad1 and Smad5, which could potentially make the cells susceptible to the phytoestrogens in soy. Neither Smad1 Smad5 deletion nor diet (soy vs. soy free) affected serum estrogen levels (Fig. 4B) [10] . To determine if genistein itself altered estrogen receptor expression in JGCT, COV434 cells were treated with genistein (50 lM) for 6 or 24 h. Quantitative PCR results showed a 25-fold increase in ESR1 expression after a 24-h incubation with genistein, whereas ESR2 was unchanged (Fig. 4, C and D) . The increase in ESR1 expression was confirmed at the protein level (Supplemental Figure S3) . 
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A few number of studies have focused on the effects of estrogen signaling in human GCT [37] or in human COV434 and KGN cell lines, and estradiol signaling in these cell lines is defective [38] . To examine the effect of genistein treatment in JGCT, we treated COV434 cells with genistein (5, 25, or 50 lM) and monitored cell viability for 72 h. The number of viable cells increased significantly at all doses of genistein as early as 24 h posttreatment (3%-9%), with a further induction occurring after 48 h (20%-34%) and 72 h (up to 51%) ( Fig. 5A and Supplemental Figure S4 ). The estrogen receptor antagonist ICI 182,780 (5 lM and 10 lM), as well as tamoxifen (all tested concentrations), statistically reduced the number of viable cells as early as 24 h when cells were cotreated with genistein (Fig.  5, B and C) . The statistical analysis for each treatment and for each dose tested is shown in Supplemental Table S3 .
Genistein Represses Apoptosis in JGCT
Our data indicated that genistein could promote cell survival in a human JGCT cell line, which may be due to a positive regulation of the cell cycle or through inhibition of apoptosis. Recent publications show that genistein's effects on apoptosis depend on cell type [39, 40] . We therefore hypothesized that genistein induced cell survival in JGCT by inhibiting intracellular apoptogenic initiators, such as the caspases.
FIG. 4. Diet differentially alters
granulosa cells from control mice fed a soy-free diet (white; n ¼ 5) or a soy-based diet (black; n ¼ 5) and from Smad1 Smad5 dKO mice fed a soy-free (white; n ¼ 7) or a soy-based diet (black; n ¼ 5). Preovulatory granulosa cells were collected from 3-wk-old prepubertal mice following PMSG treatment (46 h). Diet induced opposite changes in control and Smad1 Smad5 dKO mice. B) Serum estradiol from 12-wk-old mice measured by RIA does not change between genotypes or diets (n ¼ 7 per genotype). C) Genistein induces ESR1 but not ESR2 expression in COV434 cells after 24 h of treatment. COV434 cells were treated with genistein (50 lM) for 6 or 24 h or with DMSO (0.1%) as control. Data from n ¼ 4 independent replicates are shown. Relative quantities (RQ) of mRNA expression for (C) ESR1 and (D) ESR2 are presented. Fold change is expressed in arbitrary units relative to the mean of the control samples. GAPDH was used as a housekeeping gene to normalize samples. Data are mean 6 SEM. Statistical difference of the means compared to the control mean is indicated by the asterisks above the bars (i.e., *P , 0.05, **P , 0.01). 
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Caspase 3 is the main protagonist of apoptosis [41] . To determine the potential mechanism by which genistein could repress apoptosis, we measured caspase 3/7 activity when COV434 cells were vehicle treated or genistein treated (50 lM for 30 min) with or without a 30-min preincubation with either ICI 182,780 (10 lM) or tamoxifen (10 lM). COV434 cells treated with genistein had a 55% decrease in caspase 3/7 activity compared with the vehicle-treated cultures, which was restored to control levels when cells were preincubated with either ICI 182,780 or tamoxifen prior to genistein treatment (Fig. 6 ).
Genistein Represses Proapoptotic Gene Expression in COV434 Cells
Because the loss of apoptosis can lead to tumor initiation, growth, and progression [42] , we also examined if genistein affected expression of key pro-and antiapoptotic factors. We compared expression profiles of selected genes in COV434 cells treated with or without genistein for 24 h by qPCR. We found a significant downregulation of the proapoptotic genes (BAD, BAK1, BAX, and BOK), while antiapoptotic genes (BCL2 and BCL2L2) remained unchanged or were induced, respectively (Fig. 7) . The ratio of BCL2 to BAX rather than the levels of individual molecules is considered critical to determine the cell fate: survival or death [43] . These data would indicate that the ratio of these genes is altered with genistein treatment. To determine if similar changes occurred in Smad1 Smad5 dKO tumors in mice fed a soy diet, we compared Smad1 Smad5 dKO tumors to control granulosa cells and found a similar downregulation of proapoptotic factors such as Bak1, Bad, and Bok while antiapoptotic genes Bcl2l2 and Xiap remained unchanged or were induced (Fig. 7) .
DISCUSSION
Genistein, a component of soy, is thought to be preventive against different cancers. Epidemiologic studies have shown that an increased intake of soy products leads to a decreased risk of hormone-dependent cancer [2, 44, 45] . Nevertheless, little is known about the effects of genistein or dietary soy on granulosa cell tumors [46] . Although soy was previously shown to induce GCT [18] in one strain of mice (SWR) when administrated a diet containing daidzein and genistein, the mechanism of this phenomenon remains unclear. In the present study, we examined the effects of a soy-based diet compared to a soy-free diet on GCT development using Smad1 Smad5 dKO mice, which develop granulosa cell tumors. Our data demonstrate that dietary soy has a profound effect on tumor development in these mice. In our study, Smad1 Smad5 dKO tumors from mice fed a soy-free diet have a delay in tumor development, and the tumors that do develop are less aggressive than their soy-diet counterparts, as less than 40% of the Smad1 Smad5 dKO mice fed a soy-free diet died from their tumors within 1 yr. Furthermore, by 9 mo of age, a lower percentage of Smad1 Smad5 dKO fed a soy-free diet developed metastases compared to those fed a soy-based diet. We did not, however, find a difference in the appearance of tumor foci at earlier ages (8 or 12 wk of age). These data suggest that soy likely does not affect tumor initiation but does have a profound effect on tumor growth and progression once formed.
Several lines of evidence show active estrogen-mediated survival signaling in malignant cells [47] [48] [49] . Although steroid hormones such as estradiol contribute to the growth of cumulus cells in cooperation with oocyte-derived factors by negatively affecting cell death [50, 51] , its role in GCT has been understudied. Both estrogen receptor isoforms ESR1 and ESR2 are expressed in tumors of stromal origin, with ESR2 being expressed predominantly in granulosa cell tumors [36] . In our current study, we showed that Esr1 is upregulated in Smad1 Smad5 dKO tumor samples, whereas Esr2 is present but not regulated when compared to wild-type granulosa cells. Furthermore, we found that the human JGCT cell line COV434 had a greater expression level of ESR1 than the adult GCT cell line KGN, which was detectable at both the mRNA and the protein level. In addition, genistein treatment increased the level of ESR1. ESR1 induction may lead to an increase in estrogen responsiveness in JGCT, as suggested in a breast cancer cell line [52] .
Genistein is the main soy isoflavone and has the highest estrogenic potency of all soy constituents [53] . In vitro and in vivo studies have clearly demonstrated that genistein exhibits estrogenic activity [26, 54] and tyrosine kinase inhibitory activity [20] . Despite epidemiologic studies that show no impact of genistein in epithelial ovarian carcinogenesis [55] , based on our in vivo data, we hypothesized that genistein, perhaps in part by modulating Esr1 expression, enhances GCT development. By treating COV434 cells with genistein, we showed a clear effect for an increased number of viable cells. The effects of genistein were attenuated in the presence of the antiestrogen factors, tamoxifen, or ICI 182,780, suggesting that genistein may act through an ER-dependent mechanism. Furthermore, the effects of genistein on GCT viability were in part due to a repression of apoptosis, as shown by the ability of genistein treatment to downregulate caspase 3/7 activity. Thus, by repressing apoptosis, genistein is able to promote GCT development.
The estrogen receptor signaling pathway is crucial to maintain granulosa cells in the mature gonad [56] . Moreover, estrogen signaling has a protumor activity based on two associated mechanisms: transcriptional repression of proapoptotic molecules, such as Bak1, and enhanced transcription of antiapoptotic factors, such as Bcl2 [57, 58] . Several studies report that genistein regulates genes related to control of the cell cycle, cell proliferation, apoptosis, and angiogenesis [59] [60] [61] [62] . Our study shows that genistein treatment represses proapoptotic gene expression (BAD, BAK1, BAX, BOK), while 
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antiapoptotic genes either increase (BCL2L2) or are unchanged (BCL2). The same target genes are similarly regulated in Smad1 Smad5 dKO tumors from mice fed a soy-based diet. Apoptosis and cell survival result from a disruption in the balance between pro-and antiapoptotic gene expression. An increase in the BCL2 family of proteins promotes cell survival by sequestrating BAX and BAK proteins [63] , therefore maintaining mitochondrial membrane integrity [64] . Proapoptotic factors are directly downregulated by genistein, leading to a shift in the BCL2/BAX ratio toward cell survival [43] . While the estrogen-signaling pathway was speculated to have a minimally direct role on tumor development [65] , our study F] ) by genistein treatment (n ¼ 4 independent replicates per treatment group). G-L) Proapoptotic genes are also downregulated in tumors from Smad1 Smad 5 dKO mice (TU) compared to control granulosa cells (GC); (G) Bak, (H) Bad, (J) Bok, but not Bax (C) mRNA expression levels are strongly downregulated in Smad1 Smad 5 dKO tumors (n ¼ 9 independent samples) compared to granulosa cells from cre-negative littermates (n ¼ 4 independent samples), while antiapoptotic genes remain either unchanged, as for Bcl2l2 (K), or increased, such as Xiap (L), in tumors. Relative quantity of mRNA expression level is shown using SYBR green quantification. CT values were normalized to Gapdh (mean DCT). The mean DCT of the control samples (either vehicle treated [DMSO] for A-F or cre-negative granulosa cells [G-L]) was used as the calibrator sample for relative expression. Statistical analysis was performed by a Student t-test for each gene. Statistical difference between means is indicated by the asterisks above the bar (*P , 0.05, **P , 0.01, ***P , ,0.001); ns, not significant.
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demonstrates a growth-promoting role in vivo in mouse and in vitro in human juvenile GCT.
Our current study demonstrates that dietary soy and, in particular, genistein may provide a protective signal in JGCTs, preventing them from undergoing apoptosis, which ultimately enhanced tumor development. This action was triggered through regulation of estrogen receptor expression and signaling, which could also potentially lead to a pleiotropic effect on prosurvival pathways, such as the PI3K/AKT pathway. The effect of isoflavones in enhancing JGCT growth, in mice and in a human JGCT cell lines, is problematic, as there is a trend toward increased inclusion of soy in the diets of adults and infants worldwide. In total, our studies would suggest further investigations into a potential effect of dietary soy in children and women with JGCT.
